BlueGnome Spinout Sure Laboratories Aims to Serve Growing IVF Screening Market
September 07, 2010
BlueGnome Spinout Sure Laboratories Aims to Serve Growing IVF Screening Market
The new firm, founded to take advantage of a "rapidly growing" market for pre-implantation genetic screening services, will directly offer BlueGnome's 24Sure platform to in vitro fertilization centers in Europe.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BlueGnome Licenses Karyomapping IP in Bid to Bolster Pre-Implantation Genetic-Dx Play
October 19, 2010 / BioArray News - Study Backs BlueGnome CGH Arrays as Screening Tool to Improve IVF Success Rates
May 8, 2012 / BioArray News - Illumina's Q4 Array Revenues Climb 4 Percent on BlueGnome Addition, HumanCore Demand
January 29, 2013 / BioArray News - Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
October 30, 2012 / BioArray News - With BlueGnome Buy, Illumina Expands Presence in Cyto Market, Moves into IVF Testing
September 25, 2012 / BioArray News